Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

DF Deutsche Forfait Aktie 32859959 / DE000A2AA204

30.09.2025 11:27:04

EQS-News: Half-year report 2025 published

EQS-News: DF Deutsche Forfait AG / Key word(s): Half Year Report
Half-year report 2025 published

30.09.2025 / 11:27 CET/CEST
The issuer is solely responsible for the content of this announcement.


  • Core business remains on track
  • Diversification in progress

Cologne, 30 September 2025 – DF Deutsche Forfait AG (ISIN: DE000A2AA204) (DF AG) published its half-year report 2025 today.

The core business in the ‘Trade Finance’ segment continues to develop positively. Business volume rose to EUR 118.1 million in the first half of 2025 (previous year: EUR 105.1 million), exceeding expectations with an increase of around 12%. Gross profit, generated primarily from trade finance, also increased by around 23% to EUR 5.8 million (previous year: EUR 4.7 million).

Earnings before taxes (EBT) amounted to EUR 1.1 million in the first half of 2025, significantly below the previous year's figure of EUR 2.0 million. This was primarily due to the significant increase in personnel costs as a result of the acquisitions of DF Vagabund and DF Blutplasma as of the reporting date, as well as additional investments and start-up costs for the establishment of these new segments. Consolidated earnings for the first half of 2025 amounted to EUR 0.4 million or EUR 0.04 per share (previous year: EUR 1.5 million or EUR 0.12 per share).

DF AG's cash and cash equivalents totalled EUR 31.1 million as of 30 June 2025 and additionally EUR 7.0 million from other current assets.

‘The first half of 2025 was marked by investments in the DF Vagabund in Berlin and the acquisition of the assets of a blood plasma company in Bochum,’ explains CEO Dr Behrooz Abdolvand. ‘This has enabled us to further diversify our expertise in the food & beverage and health & pharmaceuticals sectors, and we are well on track to generate positive returns from these business areas in the medium term. Although the geopolitical changes in the Middle East have no direct impact on our existing business, they do affect the way we conduct our business. At the same time, we are broadening our base in order to develop new business outside our existing target markets.’

The auditors have issued a report on their audit review.

As already reported in the ad hoc announcement of 26 September 2025, the Management Board expects a slight increase in business volume of between 5% and 10% for the current financial year 2025. At the same time, gross profit is still expected to increase by 15% to 25% and earnings before taxes to decline by around 50%.

The half-year report is available on our website at https://www.dfag.de/en/investor-relations/publications/

About DF Group

The DF Group is a listed financial and investment company with business divisions in trade finance, food & beverage, and health & pharma. In its core business of foreign trade financing, the DF Group has decades of experience, a strong international network, and proven compliance expertise with a regional focus on the Middle East, Europe, and Central Asia. With its investments in the food & beverage and health & pharma sectors, the DF Group is consistently expanding its diversification strategy and developing new sources of income in high-growth industries. M&A activities are also an integral part of the business model.

 Contact DF Deutsche Forfait AG

Guido Janzen
Director Investor Relations
Gustav-Heinemann-Ufer 56, 50968 Köln
T +49 221 97376-61

E investor.relations@dfag.de
www.dfag.de



30.09.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: DF Deutsche Forfait AG
Gustav-Heinemann-Ufer 56
50968 Köln
Germany
Phone: +49 221 97376 - 0
E-mail: dfag@dfag.de
Internet: www.dfag.de
ISIN: DE000A2AA204, DE000A1R1CC4,
WKN: A2AA20, A1R1CC
Listed: Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2205970

 
End of News EQS News Service

2205970  30.09.2025 CET/CEST

Analysen zu DF Deutsche Forfait AG

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
Zu diesem Datensatz liegen uns leider keine Daten vor.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

ETFs oder Dividendenaktien – welcher Weg führt langfristig zum Erfolg

In der BX Swiss Bloggerlounge am Börsentag Zürich 2025 diskutieren Helga Bächler von liebefinanzen.ch, Angela Mygind (MissFinance) und Olivia Hähnel (BX Swiss) über zwei Strategien mit dem gleichen Ziel: finanzielle Freiheit. Im Gespräch geht es um die entscheidende Frage: 👉 Ist passives Investieren mit ETFs wirklich der bessere Weg oder lohnt sich aktives Stock-Picking doch mehr?

💬 Themen im Überblick:
💡 Vor- & Nachteile von ETFs und Einzelaktien
💡 Welche Risiken Anlegerinnen und Anleger kennen sollten
💡 Wie Dividenden motivieren können
💡 Tipps für Einsteigerinnen und Einsteiger
💡 Umgang mit Rückschlägen an der Börse

Ein besonderes Highlight auf dem diesjährigen Börsentag Zürich war die BX Swiss Bloggerlounge. Bekannte YouTuber und Finanz-Influencer standen für Gespräche und Diskussionen bereit und vermittelten Ihr Wissen und Ihre Erfahrungen in Vorträgen.

👉🏽 Jetzt auch auf BXplus anmelden und von exklusiven Inhalten rund um Investment & Trading profitieren!

ETFs oder Dividendenaktien – welcher Weg führt langfristig zum Erfolg

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 12’968.69 19.76 BA5S0U
Short 13’251.94 13.53 BU9S6U
Short 13’718.62 8.92 U9VBSU
SMI-Kurs: 12’484.80 13.10.2025 17:31:14
Long 11’894.46 18.86 SKIBKU
Long 11’658.64 13.83 S7MBDU
Long 11’139.27 8.80 BNJS4U
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com